1376O The effect of hyperthermic intraperitoneal chemotherapy (HIPEC) upon cytoreductive surgery (CRS) in gastric cancer (GC) with synchronous peritoneal metastasis (PM): A randomized multicentre phase III trial (GASTRIPEC-I-trial)
2021; Elsevier BV; Volume: 32; Linguagem: Inglês
10.1016/j.annonc.2021.08.1485
ISSN1569-8041
AutoresBeate Rau, Hauke Lang, Alfred Königsrainer, Ines Gockel, H. Rau, Hendrik Seeliger, Christian Lerchenmüller, Daniel Reim, Roger Wahba, Martin K. Angele, Steffen Heeg, Tobias Keck, Arved Weimann, Sascha Topp, P. Piso, Andreas Brandl, Evelyn Trips, Volker Heinemann, P. Thuss-Patience,
Tópico(s)Gastrointestinal Tumor Research and Treatment
ResumoIn patients (pts) with PM from GC, palliative chemotherapy (CTx) is the treatment of choice. CRS and HIPEC is still matter of debate, as the evidence is controversial. We conducted a randomized controlled multicentre trial to explore the impact of HIPEC after CRS on overall survival (OS). (Funding German Cancer Aid; ClinicalTrials.gov, number NCT02158988).
Referência(s)